• The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, in its acquisition of Green Roads worth up to $60 million.
• Cultivate Holdings in executing a definitive agreement to sell 100% of its business to Cresco Labs (CSE:CL) (OTCQX:CRLBF), for upfront consideration equal to $90 million plus an earnout of up to $68 million.
• Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a multi-state cannabis operator, in a wide variety of matters, including:
  
  • an underwritten public offering worth approximately US$228 million of subordinate voting shares
  • in its C$115.5 million offering of subordinate voting share
  • completion of a Registration Statement on Form S-1 in U.S, and subsequent filings
  • in sale-leaseback transaction with Innovative Industrial Properties, Inc.
  • assisting in drafting the second-highest-scoring Application out of 69 competitive applications in the State of Georgia, receiving a Notice of Intent to Award one of only two Class 1 Production Licenses
  • asset purchases of a Final Marijuana Retailer License in Worcester and a Provisional Marijuana Retailer License in Framingham, and related entitlements. The transactions include cash and stock consideration.
• Columbia Care Inc. (OTCMKTS: CCHWF) in a number of matters, including:
  
  • its acquisition of Green Leaf Medical, LLC, a fully-integrated cannabis multi-state operator based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments
  • its $42.5 million acquisition of the Van de Wetering Greenhouses
  • its $69 million acquisition of Project Cannabis, a leading California cannabis cultivator, wholesaler and retailer
  • its $140 million acquisition of The Green Solution, a Colorado-based vertically integrated cannabis company
  • in national and state-level intellectual property, patent and trademark filings and related matters
  • its pending $42 million acquisition of Medicine Man Denver, a vertically integrated operator in Colorado.
• New England Treatment Access, LLC (NETA), a leading Massachusetts-based cannabis company, in its sale to Surterra Wellness.
• Ethos Cannabis in $18 million acquisition of 4Front Venture Corp’s assets in Pennsylvania and Maryland, including five operating dispensaries.
• Ascend Wellness Holdings (OTCMKTS: AAWH) in a number of matters, including:
  
  • its majority investment in MedMed New York
  • its acquisition of Greenleaf Compassion Center, a vertically integrated Cannabis company that holds one of the original six Alternative Treatment Center licenses in New Jersey.
• General Counsel to the New Jersey Cannabis Trade Association, (NJCTA), the trade association for the licensed Alternative Treatment Centers, and several of its members.
• Drafted application in New Jersey competitive RFP for Vertically Integrated ATCs with client NETA NJ that scored highest out of applications from more than 146 applicants.
• Drafted, project managed and submitted more than 20 competitive RFP applications for numerous clients in Georgia, Virginia, Illinois, Missouri, New Jersey, and Utah, including multiple winning applications
• Advising foreign company on NASDAQ listing.
• Provide several clients with regulatory compliance advice regarding the production and distribution of industrial hemp and CBD products, including FDA matters.
• Represented private company in acquisition of controlling interest in Florida MMTC.
• An investment fund in all phases of $23 million investment and acquisition of Massachusetts cultivation, retail operations and real estate.
• Assist clients in drafting applications to Massachusetts Cannabis Control Commission for state marijuana establishment licenses, and successfully secure critical zoning approvals and local approvals.
• Successfully represented clients in securing positive resolution of compliance issues and enforcement orders with Massachusetts Cannabis Control Commission.
• Structured Holding Company for MSO’s subsidiaries in five states and $70mm Capital Raise
• Structured cannabis focused venture fund and parallel fund for direct investments.
• Advise several qualified social equity applicants on founder matters, corporate structuring, financing, and regulatory compliance.
• Represented medical marijuana patients in successful challenge to the Governor’s temporary ban on the sale of cannabis vaporizer products in Massachusetts, securing a preliminary injunction against the ban and defending the validity of the ruling on appeal.
• Currently represent multiple different cannabis companies with regard to union organizing efforts spurred by the labor movement’s desire to organize the industry, particularly in Massachusetts, Illinois and California.
• Negotiated and structured complex joint venture for applicant of dispensary, cultivation and manufacturing licenses, including a debt facility of up to $5 million, and several other production facility joint ventures.
• Negotiated Wholesale, Branding, White-Labeling, Master Services, Licensing, and other commercial agreements on behalf of clients in multiple jurisdictions.
• Large real-estate investor in multiple cannabis-related acquisitions.
• Dozens of clients in multiple states on a variety of formation, structuring, and founder matters.
• Multiple operators at various stages of development and investors in private placements of debt and equity securities.
• Serve as U.S. counsel to national operator with licenses in 13 U.S. states in business combination with NEO-Exchange-traded company.
• National operator in acquisition of chain of Michigan dispensaries.
• CSE-traded MSO in strategic acquisitions in multiple states and national real estate matters.
• Represent CSE-traded company on $60 million acquisition of cannabis company; and serve as special tax and regulatory counsel.
• Counsel emerging ancillary technology and services companies on variety of business and regulatory matters.Advised dispensary owner in arbitration with investor regarding terms of the investor’s exit, and related refinancing.